Key Metrics
CiteScore 

18.8
Eigenfactor 

0.01 - 0.05
H-Index 

150
Impact Factor 

15 - 20
Scite Index 

0.89 5-Year SI

SJR 

Q1Oncology

SNIP 

3.17
Recommended pre-submission checks
Powered by 

Topics Covered on Neuro-Oncology
Neuro-Oncology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Neuro-Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Neuro-Oncology
The emerging roles of cerebral pericytes in brain metastasis.
- 19 May 2026
- Neuro-oncology
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
- 19 May 2026
- Neuro-oncology
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
- 19 May 2026
- Neuro-oncology
CIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.
- 18 May 2026
- Neuro-oncology
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas.
- 15 May 2026
- Neuro-oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
- 14 May 2026
- Neuro-oncology
The emerging roles of cerebral pericytes in brain metastasis.
- 19 May 2026
- Neuro-oncology
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
- 19 May 2026
- Neuro-oncology
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
- 19 May 2026
- Neuro-oncology
CIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.
- 18 May 2026
- Neuro-oncology
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas.
- 15 May 2026
- Neuro-oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
- 14 May 2026
- Neuro-oncology